Latest Heart failure Stories

- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass., and SYDNEY, June 17, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE...

Supplemental CoQ10, such as Liquid Health's Hydrosoluble CoQ10 is especially important for people with heart problems. A study presented at Heart Failure 2013 Congress found that CoQ10 can decrease deaths related to heart failure by 50%. Murrieta, CA (PRWEB) June 14, 2013 Professor Svend Aage Mortensen, lead author, presented his study's findings at Heart Failure 2013 Congress in Lisbon, Portugal. At the annual meeting of the Heart Failure Association of the European Society of...

FRAMINGHAM, Mass. and SYDNEY, June 13, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 9:25 a.m. EDT on Tuesday, June 18, 2013. The conference is being held June...

Two Additional Top Children's Hospitals Ready to Perform 1st SynCardia Total Artificial Heart Implant TUCSON, Ariz., June 13, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named seven SynCardia Certified Centers among the nation's "Best Children's Hospitals" for cardiology and heart surgery in its...

As many as 39 recently diagnosed heart failure patients who meet specified health and financial-need criteria can participate -- free of charge -- in a four-month exercise rehabilitation program cooperatively administered by the Congestive Heart Failure Clinic and Cardiac Rehabilitation program at St. Joseph Health Center. Warren, OH (PRWEB) June 06, 2013 Recently diagnosed heart failure patients in Trumbull County are benefiting from a Humility of Mary Health Partners pilot program...

ST. LOUIS, June 5, 2013 /PRNewswire-USNewswire/ -- A research team led by Theodosios Alexander, Sc.D., Dean of Parks College Engineering, Aviation and Technology at Saint Louis University, was awarded $1.4 million (GBP886k) by the Invention for Innovation (i4i) Program of the National Institute for Health Research to develop a novel mechanical circulatory support device. The proposal is titled TURBOCARDIA: Mechanical Circulatory Support Installed via Minimally Invasive Surgery....

HUNTSVILLE, Ala., June 5, 2013 /PRNewswire/ -- EGEN, Inc., a clinical stage biopharmaceutical company, announced today that EGEN's proprietary lung targeting Staramine-mPEG nanoparticle delivery system has been used to administer an inhibitor of microRNA-145 (anti-miRNA-145) in a rat model of severe occlusive PAH. Treatment was shown to significantly reverse the pulmonary hypertension associated with the advanced stages of the disease and restore cardiovascular function. This...

FRAMINGHAM, Mass. and SYDNEY, June 4, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Goldman Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 am EDT) on Wednesday, June 12, 2013. The conference is being held June...

A rare disease can make a patient feel very alone -- just ask Kristen Wieneke of St. Franci, Wis. Meeting many others from around the country with the same lung disease has inspired her to plan a June 15 event to raise awareness and funds for the Pulmonary Hypertension Association. St. Francis, WI (PRWEB) June 03, 2013 A rare disease can make a patient feel very alone – just ask Kristen Wieneke of St. Francis. Wieneke had been living with a life-threatening lung disease, pulmonary...

PALO ALTO, Calif., May 30, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Jefferies 2013 Global Healthcare Conference, taking place June 3-6, 2013 in New York, NY. David Levison, the company's President and Chief Executive Officer, will provide an overview of CardioDx and Corus(®) CAD, the only clinically validated gene expression test for obstructive coronary artery disease (CAD)...